ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -28 مورد

Seventh World Symposium on Pulmonary Hypertension (WSPH): Risk stratification

Seventh World Symposium on Pulmonary Hypertension (WSPH): Risk stratification
6MWD: six-minute walk distance; CTD: connective tissue disease; DT: drug and toxin; ERA: endothelin-1 receptor antagonist; FC: functional class; HPAH: hereditary PAH; IPAH: idiopathic PAH; mPAP: mean pulmonary artery pressure; RV: right ventricle; Rx: prescription; PAH: pulmonary arterial hypertension; PDE-5i: phosphodiesterase-5 inhibitor; PPA: prostacyclin pathway agent; PVR: pulmonary vascular resistance; sGCS: soluble guanylyl cyclase stimulator.
Reproduced with permission of the ERS 2024. Chin KM, Gaine SP, Gerges C, et al. Treatment algorithm for pulmonary arterial hypertension. Eur Respir J 2024; 64: 2401325 [DOI: 10.1183/13993003.01325-2024].
Graphic 129504 Version 2.0